Federated Hermes, Inc. Alx Oncology Holdings Inc Transaction History

Federated Hermes, Inc.

$43.9 Billion
Q1 2025

A detailed history of Federated Hermes, Inc. transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 6,541 shares of ALXO stock, worth $3,205. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,541

Previous 4,483 45.91%

Holding current value

$3,205

Previous $7,000 42.86%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$0.62 - $1.86 $1,275 - $3,827	2,058 Added 45.91%	6,541 $4,000
Q4 2024 Feb 13, 2025	BUY	$1.21 - $1.87 $5,424 - $8,383	4,483 New	4,483 $7,000
Q2 2024 Aug 08, 2024	SELL	$5.84 - $17.56 $1.16 Million - $3.5 Million	-199,033 Reduced 98.84%	2,329 $14,000
Q1 2024 May 14, 2024	BUY	$10.95 - $16.79 $52,844 - $81,028	4,826 Added 2.46%	201,362 $2.25 Million
Q4 2023 Jan 31, 2024	SELL	$4.81 - $15.38 $263,703 - $843,193	-54,824 Reduced 21.81%	196,536 $2.93 Million
Q3 2023 Nov 13, 2023	SELL	$4.19 - $7.35 $15,125 - $26,533	-3,610 Reduced 1.42%	251,360 $1.21 Million
Q2 2023 Aug 14, 2023	SELL	$4.37 - $9.56 $1.12 Million - $2.44 Million	-255,696 Reduced 50.07%	254,970 $1.91 Million
Q1 2023 May 08, 2023	BUY	$4.52 - $11.71 $210,799 - $546,119	46,637 Added 10.05%	510,666 $2.31 Million
Q4 2022 Feb 13, 2023	SELL	$9.51 - $12.95 $6,514 - $8,870	-685 Reduced 0.15%	464,029 $5.23 Million
Q3 2022 Nov 14, 2022	BUY	$8.23 - $15.14 $65,519 - $120,529	7,961 Added 1.74%	464,714 $4.45 Million
Q2 2022 Aug 15, 2022	BUY	$5.89 - $19.46 $2.37 Million - $7.84 Million	402,646 Added 744.17%	456,753 $3.7 Million
Q1 2022 May 13, 2022	BUY	$13.65 - $22.06 $738,560 - $1.19 Million	54,107 New	54,107 $914,000
Q4 2020 Feb 12, 2021	SELL	$34.11 - $112.26 $170,550 - $561,300	-5,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$29.36 - $47.1 $146,800 - $235,500	5,000 New	5,000 $188,000

Others Institutions Holding ALXO

# of Institutions

Shares Held

35.3M

Call Options Held

34K

Put Options Held

36.9K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $20M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Alx Oncology Holdings Inc Transaction History